Search for other papers by Ilaria Muller in
Google Scholar
PubMed
Search for other papers by Lucy S. Kilburn in
Google Scholar
PubMed
Search for other papers by Peter N. Taylor in
Google Scholar
PubMed
Search for other papers by Peter J. Barrett-Lee in
Google Scholar
PubMed
Search for other papers by Judith M. Bliss in
Google Scholar
PubMed
Search for other papers by Paul Ellis in
Google Scholar
PubMed
Search for other papers by Marian E. Ludgate in
Google Scholar
PubMed
Search for other papers by Colin M. Dayan in
Google Scholar
PubMed
variable: euthyroid (FT4 and TSH within the normal ranges), hypothyroid (FT4 <9.0 pmol/L and/or TSH >4.40 mIU/L), and hyperthyroid (FT4 >19.1 pmol/L and/or TSH <0.3 mIU/L). Statistical Analysis According to TPOAb prevalence in age-matched females of
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
hyperthyroidism and low in overt hypothyroidism [ 9 ]. However, measurable differences in REE have been described also with smaller variation in thyroid function. al-Adsani et al. [ 10 ] found changes in REE of 7–8% when the dose of L-T 4 to hypothyroid patients
Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed
infarction, heart failure, and stroke are other common risk factors for AF ( 3 ). Today, the increased knowledge of the genetic causes of AF has revealed around 140 genetic loci associated with AF ( 4 ). Hyperthyroidism is also a common condition with an
Search for other papers by Katarzyna Pelewicz in
Google Scholar
PubMed
Search for other papers by Rafał Wolny in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by Piotr Miśkiewicz in
Google Scholar
PubMed
it can persist causing hypothyroidism. A pathologic response to the exogenous iodine load may lead to iodine-induced hyperthyroidism (IIH), known as the Jod-Basedow phenomenon. IIH is infrequent, but elderly patients and individuals with autonomously
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Overt thyroid dysfunction in pregnant women is defined by TSH and T4 outside of the pregnancy- and method-specific reference ranges [ 6 ]. Clinical guidelines unanimously state that overt hyperthyroidism caused by Graves’ disease as well as overt
Search for other papers by Thea Riis in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
, 12 ). It is unsettled whether these pathophysiological observations can translate into an increased risk of non-thyroid cancer in patients with hyperthyroidism ( 13 ). Results from some ( 14 , 15 , 16 , 17 , 18 ), but not all ( 19 , 20 , 21
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
Introduction Graves' disease (GD) is an autoimmune disease of the thyroid gland and is the most common cause of hyperthyroidism. The annual incidence is 20–50 cases per 100,000 people, with a peak incidence between the ages of 30 and 50. The
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Search for other papers by Stan R Ursem in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Search for other papers by Eveline Bruinstroop in
Google Scholar
PubMed
Amsterdam Public Health Research Institute, Amsterdam UMC, The Netherlands
Search for other papers by Petra J M Elders in
Google Scholar
PubMed
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Jacobijn Gussekloo in
Google Scholar
PubMed
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Rosalinde K E Poortvliet in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Public Health Research Institute, Meibergdreef, Amsterdam, The Netherlands
Search for other papers by Wendy P J den Elzen in
Google Scholar
PubMed
Background Subclinical thyroid diseases are often the subject of debate concerning their clinical significance, the appropriateness of diagnostic testing, and possible treatment. In subclinical hyperthyroidism, there is a mild thyroid
Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Introduction Graves’ disease (GD) accounts for 75% of hyperthyroidism in iodine-replete geographical areas. Approximately one-fifth of GD patients develop Graves’ orbitopathy (GO), which is the most common extrathyroidal manifestation of GD
Search for other papers by Suvi Turunen in
Google Scholar
PubMed
Search for other papers by Marja Vääräsmäki in
Google Scholar
PubMed
Search for other papers by Maarit Leinonen in
Google Scholar
PubMed
Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
Search for other papers by Mika Gissler in
Google Scholar
PubMed
Search for other papers by Tuija Männistö in
Google Scholar
PubMed
Search for other papers by Eila Suvanto in
Google Scholar
PubMed
]. Hyperthyroidism during pregnancy occurs in 0.4–1.7% of pregnant women [ 3 , 4 ]. Both overt hypo- and hyperthyroidism as well as subclinical hypothyroidism and thyroid autoimmunity have been associated with adverse obstetrical and neonatal events such as